Novel theranostic tool allows for noninvasive identification and treatment of ovarian cancer
A radiotheranostic platform that employs a MUC16-targeting humanized antibody, huAR9.6. Ovarian cancer cells that express hypoglycosylated MUC16 residues are detected ...